Abstract:Background: Hepatocellular carcinoma (HCC) is one of the most common liver malignancies in the world. With highly invasive biological characteristics and a lack of obvious clinical manifestations, hepatocellular carcinoma usually has a poor prognosis and ranks fourth in cancer mortality. The etiology and exact molecular mechanism of primary hepatocellular carcinoma are still unclear. Objective: This work aims to help identify biomarkers of early HCC diagnosis or prognosis based on weighted gene co-expression network analysis (WGCNA). Methods: Expression data and clinical information of HTSeq-Counts were downloaded from The Cancer Genome Atlas (TCGA) database, and gene expression map GSE121248 was downloaded from Gene Expression Omnibus (GEO). By differentially expressed genes (DEGs) and weighted gene co-expression network analysis (WGCNA) searched for modules in the two databases that had the same effect on the biological characteristics of HCC, and extracted the module genes with the highest positive correlation with HCC from two databases, and finally obtained overlapping genes. Then, we performed functional enrichment analysis on the overlapping genes to understand their potential biological functions. The top ten hub genes were screened according to MCC through the string database and Cytoscape software and then subjected to survival analysis. Results: High expression of CDK1, CCNA2, CDC20, KIF11, DLGAP5, KIF20A, ASPM, CEP55, and TPX2 was associated with poorer overall survival (OS) of HCC patients. The DFS curve was plotted using the online website GEPIA2. Finally, based on the enrichment of these genes in the KEGG pathway, real hub genes were screened out, which were CDK1, CCNA2, and CDC20 respectively. Conclusions: High expression of these three genes was negatively correlated with survival time in HCC, and the expression of CDK1, CCNA2, and CDC20 were significantly higher in tumor tissues of HCC patients than in normal liver tissues as verified again by the HPA database. All in all, this provides a new feasible target for early and accurate diagnosis of HCC, clinical diagnosis, treatment, and prognosis.

A Systems Biology-Based Classifier for Hepatocellular Carcinoma Diagnosis

Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning

In-depth Characterization of the Biomarkers Based on Tumor-Infiltrated Immune Cells Reveals Implications for Diagnosis and Prognosis in Hepatocellular Carcinoma.

Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method

A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma.

Identifying the Biomarkers and Pathways Associated with Hepatocellular Carcinoma Based on an Integrated Analysis Approach

Construction of immune-related molecular diagnostic and predictive models of hepatocellular carcinoma based on machine learning

Clinical and Morpho-Molecular Classifiers for Prediction of Hepatocellular Carcinoma Prognosis and Recurrence after Surgical Resection.

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma

Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma

Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning

Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods

Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions

Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinoma

Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients

Five Critical Gene-Based Biomarkers with Optimal Performance for Hepatocellular Carcinoma.

Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay

Evaluation and Prediction of Hepatocellular Carcinoma Prognosis Based on Molecular Classification

TopMarker: Computational Screening Biomarkers of Hepatocellular Carcinoma from Transcriptome and Interactome Based on Differential Network Topological Parameters

Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis

A Blood-Based 22-Gene Expression Signature for Hepatocellular Carcinoma Identification